| DC Field | Value | Language |
|---|
| dc.contributor.author | Shelekhova, T. V. | - |
| dc.contributor.author | Ruta, A. V. | - |
| dc.contributor.author | Luchinina, E. V. | - |
| dc.contributor.author | Bontsevich, R. A. | - |
| dc.contributor.author | Zaitсeva, M. R. | - |
| dc.date.accessioned | 2026-10-12T14:11:53Z | - |
| dc.date.available | 2026-10-12T14:11:53Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | The C3435T genetic polymorphism of the ABCB1 (MDR1) gene as a predictor of antihypertensive efficacy of losartan monotherapy in newly diagnosed arterial hypertension / T.V. Shelekhova, A.V. Ruta, E.V. Luchinina [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №1.-P. 95-100. - DOI: 10.18413/rrpharmacology.12.1057. - Refer.: p. 99. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67113 | - |
| dc.description.abstract | The aim of this research is to indicate the correlation between common SNPs C3435T and C1236T of the MDR1 gene and the efficacy of 6-week losartan monotherapy course in patients with a newly diagnosed arterial hypertension (AH) | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | P-glycoprotein | ru |
| dc.subject | ABCB1 | ru |
| dc.subject | MDR1 | ru |
| dc.subject | genetic polymorphism | ru |
| dc.subject | arterial hypertension | ru |
| dc.subject | losartan | ru |
| dc.subject | personalized medicine | ru |
| dc.title | The C3435T genetic polymorphism of the ABCB1 (MDR1) gene as a predictor of antihypertensive efficacy of losartan monotherapy in newly diagnosed arterial hypertension | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 1
|
